FLASH SALE: Subscribe For Just ₹̶2̶9̶9̶9̶ ₹699
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical Trials
Shares Of US Bio Pharma Company That Struck A Deal With Bharat Biotech For Covaxin Surge 200 Per Cent In NASDAQ
Bharat Biotech Inks Pact With Ocugen For Supply Of Covaxin To US